SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Interest Receivable, Current
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) had Interest Receivable, Current of $4 as of 2024-09-30, per its 10-Q filed 2024-11-13.
Financial Statements › Notes
us-gaap:InterestReceivableCurrent · last filed 2025-02-26
- 2024-09-30: Interest Receivable, Current $4.00.
- 2024-06-30: Interest Receivable, Current $7.23K.
- 2024-03-31: Interest Receivable, Current $11.96K.
- 2023-12-31: Interest Receivable, Current $14.90K.
| Period end | Interest Receivable, Current |
|---|---|
| 2024-09-30 | $4.00 10-Q · filed 2024-11-13 |
| 2024-06-30 | $7.23K 10-Q · filed 2024-09-04 |
| 2024-03-31 | $11.96K 10-Q/A · filed 2024-09-04 |
| 2023-12-31 | $14.90K 10-K · filed 2025-02-26 |
| 2023-09-30 | $12.44K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $6.95K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $7.02K 10-Q · filed 2023-05-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |